Khunti, Kamlesh
Article History
First Online: 8 December 2020
Competing interests
: K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for AstraZeneca, Bayer, Berlin-Chemie AG/Menarini Group, Boehringer Ingelheim, Janssen, Lilly, Merck Sharp & Dohme, Napp, Novartis, Novo Nordisk and Sanofi-Aventis.